ASSIST: Treatment for Childhood Apraxia of Speech
Completed · Phase 1
Conditions studied: Childhood Apraxia of Speech
In brief
Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In four small randomized group design studies across three recruitment cycles (N=20 per cycle), children receive 16 hours of individual ASSIST. The studies systematically investigate the effect of treatment (ASSIST vs. no ASSIST; Study 1), the effect of complexity (complex vs. simple utterances; Study 2), the effect of lexicality (word vs. nonword targets; Study 3), and the effect of treatment intensity (Massed vs. Distributed ASSIST; Study 4). Studies 1 and 4 also systematically examine the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.
Key facts
- Study ID
- NCT03903120
- Run by
- Temple University
- People needed
- 51
- Starts
- 2019-04-18
- Expected to finish
- 2025-11-30
- Last updated by the study team
- 2026-05-22
Who can join
Age: 4 and older, up to 9. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age between 4;0 and 9;11 (years;months) at enrollment, based on parent report.
- From homes where the primary language spoken is English, based on parent report.
- Verbal output (50+ words) and communicative intent, as determined by the clinician and parent report.
- Speech sound disorder, as determined by a score <16th percentile on the Diagnostic Evaluation of Articulation and Phonology (DEAP) Articulation Assessment (Dodd et al., 2006) and/or the Goldman-Fristoe Test of Articulation (Goldman \& Fristoe, 2015).
- CAS as a primary speech diagnosis, based on the following criteria:
- An average rating > 1 across three expert speech-language pathologists (SLPs), who will independently rate presence of CAS in children live or from video recordings of the assessment using a 3-point scale (0 = no CAS, 1 = possible CAS, 2 = CAS). These judgments will be based on perceptual speech features of CAS (inconsistent vowel and consonant errors, difficulties achieving and transitioning into articulatory configurations, abnormal prosody).
- An Apraxia Score of 1 or 2 on a Maximum Performance protocol in which they sustain vowels and fricatives as long as possible and repeat syllables as fast as possible (Rvachew et al., 2005; Thoonen et al., 1999).
- Normal hearing based on parent report or passing a standard pure-tone audiometry hearing screening at 500, 1000, 2000, and 4000 Hz (ASHA, 1997).
- Typical nonverbal cognition as determined by a T-score within 1.5 standard deviation (SD) of the mean on nonverbal subtests of the Reynolds Intellectual Assessment Scales (Reynolds \& Kamphaus, 2003).
You may not qualify if…
- Diagnosis of disorder that significantly affects communication and/or social interactions (e.g., autism), as per referral diagnosis.
- Uncorrected vision impairments that may interfere with ability to process visual cues used in treatment, as per parent report.
- Significant impairments of oral structure (e.g., cleft palate) as judged by the SLP based on an oral mechanism exam (Robbins \& Klee, 1987).
- A primary diagnosis of dysarthria, as judged by the SLP.
- Unrelated health concerns that prevent children from participating, per parent report.
- Inability to meet toileting needs independently or separate from parent for a full day (as needed for camp), based on parent report.
Where it is running
- Temple University — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.